External auditory canal cholesteatoma presenting with facial nerve palsy: rare clinical entity Authors: Rim Marouf, Walid Bijou, Youssef Oukessou, Sami Rouadi, Redallah Abada, Mohamed Mahtar Published: 2026 ABSTRACT Introduction and importance:External auditory canal cholesteatoma (EACC) is a rare, non-neoplastic lesion representing 0.1%–0.5% of otologic cases. Despite its rarity, EACC can be highly destructive, similar to middle ear cholesteatoma. Owing to its proximity to vital structures such as the facial nerve, severe complications, including facial paralysis, may occur, although such presentations remain exceptionally uncommon and scarcely reported.Case presentation:We report the case of a 45-year-old male patient who presented to our ENT department with right-sided facial paralysis. Otoscopic examination revealed cholesteatoma debris filling the right external auditory canal (EAC), with posterior and inferior canal wall erosion but an intact tympanic membrane. CT imaging demonstrated EAC erosion extending to the vertical segment of the facial nerve, while the tympano-mastoid cavity remained intact. Surgical exploration confirmed an extensive EACC with complete destruction of the posterior wall and erosion of the inferior wall, surrounding the exposed vertical segment of the facial nerve. Complete removal of the cholesteatoma was achieved via canal-wall-down mastoidectomy, followed by facial nerve decompression and canaloplasty.Clinical discussion:EACC is a rare lesion of keratinizing epithelium confined to the bony canal, typically presenting with chronic otorrhea and dull otalgia. The diagnosis is primarily clinical, supported by high-resolution CT to assess bone erosion and disease extent. EACC is classified into three stages: stage 1, limited to the canal; stage 2, with bone erosion and/or middle ear involvement; and stage 3, extending to adjacent structures, with or without complications such as facial paralysis. EACC may be primary or secondary to factors such as surgery or radiotherapy. Management ranges from conservative debridement to surgical intervention, including canaloplasty or mastoidectomy, depending on the extent of disease.Conclusion:Facial paralysis (FP) is a rare complication of EACC, occurring in fewer than 1% of cases. Early surgical removal, ideally within 1 month of FP onset, significantly improves facial nerve recovery. Clinicians should consider EACC in patients with suspicious otoscopic findings or chronic otorrhea unresponsive to medical treatment. Introduction Cholesteatomas are abnormal, non-neoplastic proliferations of keratinizing squamous epithelium, most commonly arising in the middle ear and/or the mastoid process. External auditory canal cholesteatoma (EACC) is a rare form, accounting for only 0.1%–0.5% of otologic cases[1]. Although uncommon, EACCs have a destructive capacity comparable to that of middle-ear cholesteatomas. Their anatomical proximity to vital neurovascular structures, including the facial nerve, can lead to serious complications such as facial nerve palsy, particularly through invasion of the vertical segment of the nerve[2].HIGHLIGHTSExternal auditory canal cholesteatoma (EACC) is a rare, non-neoplastic lesion representing 0.1%–0.5% of otologic cases.Facial paralysis due to EACC is extremely rare, with an estimated incidence of less than 1% among patients with EACC.Diagnosis is primarily clinical, supported by high-resolution CT to assess bone erosion and disease extension.Early surgical removal of EACC, ideally within 1 month of the onset of facial paralysis, significantly improves facial nerve recovery.Clinicians should consider EACC in patients with suspicious otoscopic findings or chronic otorrhea unresponsive to medical treatment. HIGHLIGHTS External auditory canal cholesteatoma (EACC) is a rare, non-neoplastic lesion representing 0.1%–0.5% of otologic cases. External auditory canal cholesteatoma (EACC) is a rare, non-neoplastic lesion representing 0.1%–0.5% of otologic cases. Facial paralysis due to EACC is extremely rare, with an estimated incidence of less than 1% among patients with EACC. Facial paralysis due to EACC is extremely rare, with an estimated incidence of less than 1% among patients with EACC. Diagnosis is primarily clinical, supported by high-resolution CT to assess bone erosion and disease extension. Diagnosis is primarily clinical, supported by high-resolution CT to assess bone erosion and disease extension. Early surgical removal of EACC, ideally within 1 month of the onset of facial paralysis, significantly improves facial nerve recovery. Early surgical removal of EACC, ideally within 1 month of the onset of facial paralysis, significantly improves facial nerve recovery. Clinicians should consider EACC in patients with suspicious otoscopic findings or chronic otorrhea unresponsive to medical treatment. Clinicians should consider EACC in patients with suspicious otoscopic findings or chronic otorrhea unresponsive to medical treatment. Cases of EACC causing facial paralysis (FP) are exceptionally uncommon, with limited documentation in the literature. This report presents a rare case of facial nerve involvement in an external auditory canal (EAC) cholesteatoma, detailing the clinical presentation, imaging findings, surgical approach, and postoperative outcomes. The rarity of this entity underscores the need for heightened clinical suspicion when evaluating patients with external ear pathology and facial nerve dysfunction. This case report has been reported in line with the SCARE criteria[3]. Case report We report the case of a 45 years old male patient with no prior otological or systemic conditions and no history of trauma who presented with sudden-onset right-sided FP. Given the high prevalence of Bell’s palsy, the patient self-medicated for 2 months with corticosteroids, vitamin therapy, and motor rehabilitation sessions. Due to the absence of clinical improvement, he subsequently presented to our ENT department. The patient showed no otological symptoms, including hearing loss, ear pain, ear discharge, vertigo, or an altered sense of taste. On clinical examination, the patient presented with right-sided FP, classified as Grade VI according to the House–Brackmann grading system (Fig. 3). Otoscopy showed a right EAC filled with grayish-white epidermal debris suggestive of cholesteatoma along with erosion of the posterior and inferior canal walls, a finding that ruled out keratosis obturans (KO) from the differential diagnosis. The right tympanic membrane was intact, with no evidence of retraction (Fig. 1). Figure 1.Otoscopy shows erosion of the inferior canal wall (arrow), with cholesteatoma debris filling the auditory canal. Otoscopy shows erosion of the inferior canal wall (arrow), with cholesteatoma debris filling the auditory canal. The left ear had a similar appearance, with less epidermal debris. The rest of the otolaryngologic, general, and systemic examination was unremarkable. Pure-tone audiometry revealed a conductive hearing loss of 40 dB at the frequencies of 4000 and 8000 Hz in the right ear. Tympanometry and stapedial reflex testing were within normal limits bilaterally. The discrepancy between the patient’s subjective perception and the audiometric results can be explained by the fact that the hearing loss was confined to high frequencies, which have a limited impact on everyday speech perception. High-resolution computed tomography (HRCT) of the temporal bone revealed bilateral widening and erosion of the posterior and inferior bony EAC, extending to the vertical segment of the right facial nerve. The attic, middle ear, scutum, ossicular chain, and bony canal of the horizontal facial nerve segment remained intact, with no soft tissue density in the tympano-mastoid cavity and no evidence of tegmen tympani or sinus plate erosion or intracranial extension (Fig. 2). Figure 2.Axial CT scan of the temporal bone showing bilateral lysis of the posterior wall of the external auditory canal (green arrow), extending to the mastoid segment of the facial nerve in the right ear (red arrow). (A) Right temporal bone. (B) Left temporal bone. Axial CT scan of the temporal bone showing bilateral lysis of the posterior wall of the external auditory canal (green arrow), extending to the mastoid segment of the facial nerve in the right ear (red arrow). (A) Right temporal bone. (B) Left temporal bone. An electromyogram was performed, revealing a grade IV motor conduction block of the right superior facial nerve. Based on these findings, surgical exploration with nerve decompression was performed, revealing extensive EAC cholesteatoma with complete destruction of the posterior canal wall and erosion of the inferior wall. The bone overlying the vertical segment of the facial nerve was eroded, exposing but not invading the nerve, which was surrounded by the cholesteatoma. No cholesteatoma was detected in the middle ear. Complete excision was achieved via canal wall-down mastoidectomy, with careful decompression of the facial nerve. The exposed nerve was protected with temporal fascia, and the canal wall was reconstructed using conchal cartilage. A paraffin-impregnated dressing was placed in the outer EAC to promote healing. Histopathological examination revealed keratinizing squamous epithelium with keratin debris consistent with cholesteatoma and ruled out any neoplastic pathology of the EAC. The patient underwent dressing removal 1-week post-surgery, with satisfactory wound healing. At the second follow-up, three months postoperatively, otoscopic examination revealed complete healing of the ear. Improvement in FP was observed, with the paralysis graded as House–Brackmann grade II (Fig. 3).Figure 3.Images showing the right-sided facial paralysis at the time of diagnosis (Image A) and 3 months postoperatively (Image B). Images showing the right-sided facial paralysis at the time of diagnosis (Image A) and 3 months postoperatively (Image B). Surgical intervention on the contralateral ear was scheduled for 6 months later to ensure complete removal of the cholesteatoma and to prevent its potential progression to facial nerve involvement and paralysis, while allowing sufficient time for the right ear to heal adequately following the initial procedure. The patient was subsequently reassessed at 9 months postoperatively and was found to have persistent House–Brackmann grade II facial function with no signs of recurrence. Discussion EACC is defined as a sac-like accumulation of keratinizing epithelium confined to the bony portion of the canal. It most often manifests as chronic otorrhea with persistent, dull otalgia[1]. EACC usually affects individuals between 40 and 75 years of age and is rarely reported in younger patients. FP secondary to EACC is rare, with an estimated incidence of 0.1% to 0.5% among otologic patients. Our case represents the first documented case in Morocco[4]. Diagnosis is primarily clinical, based on otomicroscopic findings of epidermal debris within the EAC, often with localized bone erosion, which are typically sufficient to raise strong suspicion of EACC. KO must be differentiated from EACC, as it causes circumferential canal widening from concentric keratin accumulation without the focal bone erosion seen in EACC, as described by He et al. This distinction is clinically important, given the differing management approaches[5,6]. EACC can be categorized as either primary (idiopathic) or secondary. Primary EACC arises without an identifiable cause, although several etiopathogenic mechanisms have been proposed, including repetitive microtrauma, accumulation of impacted cerumen, focal osteitis, hypoxia-driven angiogenesis, and irregular keratin deposition. Chronic use of cotton swabs has also been identified as a potential risk factor, although its causal role remains uncertain. Secondary EACC is linked to predisposing factors such as prior ear surgery, radiotherapy, chemotherapy, or canal stenosis[1]. HRCT is not essential to establish the diagnosis itself but remains necessary for staging the disease and for assessing the extent of bone erosion and involvement of adjacent structures. Several classification systems have been proposed. Naim et al described a four-stage histopathological model: (I) focal epithelial hyperplasia, (II) periostitis, (III) bone erosion, and (IV) extension into adjacent structures. However, this classification lacked clinical and surgical correlation[7]. Shin later proposed a radiological staging system independent of histopathology, with four stages: (1) confined to the EAC, (2) involving the tympanic membrane or middle ear, (3) with mastoid cell involvement, and (4) extending beyond the mastoid[8]. More recently, Hn et al developed a clinically oriented classification incorporating treatment recommendations: (1) EACC without bone erosion or middle ear involvement; (2) EACC with bone erosion, with or without middle ear involvement; (3) EACC with bone erosion and extension into adjacent structures such as the temporomandibular joint, mastoid, facial canal, jugular bulb, or dura mater. Stage 3 is further subdivided into (3a) without complications and (3b) with complications, such as FP. In our case, the patient presented with stage (3b) disease[5]. Management strategies range from conservative debridement to surgical intervention. In early or limited stages, the condition can often be managed conservatively through regular microscopic debridement performed in the outpatient setting, with or without local anesthesia. This approach, however, requires a compliant patient and consistent follow-up. A conservative strategy may also be appropriate for patients with significant comorbidities who are poor surgical candidates, or for those who prefer a non-surgical option while maintaining strict adherence to clinical monitoring. Some authors, however, advocate surgical treatment in all cases, given that bone involvement may exceed what is clinically apparent[8,9]. Surgery is indicated in cases of disease progression, extensive bone erosion, middle ear involvement, or persistent symptoms despite adequate conservative therapy. Additionally, when the disease threatens critical structures, such as the facial nerve or other adjacent areas, surgical intervention becomes imperative to prevent further complications[10,11,12]. Multiple surgical approaches have been described, including transcanal, endaural, and retroauricular techniques. The primary objectives of surgery are complete removal of the cholesteatomatous lesion and anatomical reconstruction of the EAC to restore a self-cleaning mechanism. Depending on the extent of disease, this may involve canaloplasty or a closed mastoidectomy; in more advanced cases, an open mastoidectomy may be warranted[5]. Long-term follow-up is essential regardless of whether conservative or surgical management is undertaken, as recurrence may occur even many years after initial treatment – one 20-year study reported a recurrence 13 years post-surgery[5]. Conclusion FP in the context of EAC cholesteatoma is a very uncommon complication, with a prevalence below 1%, aligning with the rarity of EAC cholesteatoma overall. Surgery should not be delayed, as early removal – within 1 month of FP onset – improves the likelihood of facial nerve recovery. EACC should therefore be considered in any patient with suspicious otoscopic findings or chronic otorrhea unresponsive to medical treatment[13].